The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Calcineurin Inhibitor Pain Syndrome: A Case Report & Literature Review

Calcineurin Inhibitor Pain Syndrome: A Case Report & Literature Review

March 18, 2019 • By Priyanka Iyer, MD, MPH

  • Tweet
  • Email
Print-Friendly Version / Save PDF

CHICAGO—Medications have frequently been implicated as a cause of musculoskeletal complaints, including persistent arthralgias, arthritis and myalgias.1 The list of offending agents is diverse, and the degree of symptoms is variable. In the world of transplant recipients, this list is exhaustive and includes immunosuppressive agents (cyclosporine, tacrolimus); myeloid growth factors, such as G-CSF; antibiotics (quinolones); and antifungal drugs (voriconazole).

You Might Also Like
  • Cancer-Associated Myositis: A Case Report & Review of the Literature
  • Fellows’ Forum Case Report: Palmar Fasciitis & Polyarthritis Syndrome
  • Rheumatology Case Report: TINU Syndrome with Concomitant Synovitis
Explore This Issue
March 2019

Additional etiologies for musculoskeletal complaints may include hyperuricemia and gouty arthritis, osteoporosis, aseptic necrosis of the femoral head and septic arthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Calcineurin inhibitor pain syndrome (CIPS) is a rare syndrome, characterized by symmetric lower extremity arthralgias and long bone pain, seen among patients currently on treatment with calcineurin inhibitors.

Below, we discuss the case of a patient who presented with bilateral symmetric knee pain while on cyclosporine. Our case highlights the importance of keeping CIPS on the differential diagnosis when a transplant recipient presents with arthralgias and bone pain. It also elucidates the challenges of treating this entity.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Case Report

A 53-year-old man who had received a liver transplant for a diagnosis of alcoholic cirrhosis was referred to the rheumatology clinic for unremitting knee and lower extremity pain, fatigue and myalgias.

Approximately one month after his transplant, he complained of polyarthralgia, predominantly affecting the large joints (shoulders, knees, back and ankles), for which he had been treated with prednisone. Consequently, most of his arthralgias resolved, except for persistent knee pain.

He was then evaluated at his primary care physician’s office, where a physical examination revealed bilateral crepitus in his knees. Knee X-rays showed evidence of bilateral, medial joint space narrowing (see Figures 1 and 2). An initial diagnosis of osteoarthritis was made, and he was referred to physical therapy for quadriceps strengthening.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Within six months, however, the patient’s pain had significantly worsened. He couldn’t walk without assistance and, consequently, needed crutches. At this time, about a year after his transplant, he was referred to the rheumatology clinic.

In the clinic, the patient described intense, constant pain, primarily in both knees, but also affecting his legs. This was constant, disabling and present throughout the day, without a morning predilection. His past medical history was significant for hypothyroidism, hypertension and gastroesophageal reflux disease. He was on several medications, including cyclosporine for immunosuppression and acetaminophen, which he used as an analgesic.

The musculoskeletal exam was notable for bilateral quadriceps atrophy, crepitus in the knees and small, bilateral knee effusions. The rest of his physical examination proved unremarkable.

The initial laboratory workup revealed mild anemia (hemoglobin 11.4 g/dL), an elevated sedimentation rate (64 mm/hr) and an elevated alkaline phosphatase (ALP) level (261 U/L). Because his other markers of liver function were normal, a bone-specific alkaline phosphatase was checked, which returned elevated (30 µg/L). The remainder of his labs were unremarkable.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Meeting Reports Tagged With: 2018 ACR/ARHP Annual Meeting, calcineurin inhibitor, calcineurin inhibitor pain syndrome, immunosuppressive drugsIssue: March 2019

You Might Also Like:
  • Cancer-Associated Myositis: A Case Report & Review of the Literature
  • Fellows’ Forum Case Report: Palmar Fasciitis & Polyarthritis Syndrome
  • Rheumatology Case Report: TINU Syndrome with Concomitant Synovitis
  • Case Report: A Patient Presents with Rare, Fulminant SAPHO Syndrome

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)